Clinical Trial Update: Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the safety, tolerability, and efficacy of a prophylactic Streptococcus pneumoniae vaccine after deliberate S. pneumonia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections
• Pneumococcal Pneumonia

Drugs mentioned

• Prophylactic S. Pneumoniae Vaccine

Snippet

Sponsor: Genocea Biosciences, Inc. | Conditions: Pneumococcal Infections, Pneumonia, Pneumococcal | Phase 2 | Status: COMPLETED